The use of low-molecular-weight heparins in pregnancy--how safe are they?
about
Interventions for preventing osteoporosis in women on heparin therapy during pregnancyInterventions for preventing osteoporosis in women on heparin therapy during pregnancyEfficacy and safety of two doses of low molecular weight heparin (enoxaparin) in pregnant women with a history of recurrent abortion secondary to antiphospholipid syndrome.Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome.Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin.Identification of a Monoclonal Antibody That Attenuates Antiphospholipid Syndrome-Related Pregnancy Complications and Thrombosis.ApoE Receptor 2 Mediation of Trophoblast Dysfunction and Pregnancy Complications Induced by Antiphospholipid Antibodies in MiceOutcomes in women receiving low-molecular-weight heparin during pregnancy.New Insights into the Molecular Basis of the Antiphospholipid Syndrome.Fondaparinux as an alternative anticoagulant therapy during pregnancy.Birthweight in pregnant women with protein S deficiency treated with low-molecular-weight heparin: a retrospective cohort study.Low-Molecular-Weight Heparin for the Treatment of Unexplained Recurrent Miscarriage With Negative Antiphospholipid Antibodies: A Randomized Controlled Trial.Placental Drug Transport-on-a-Chip: A Microengineered In Vitro Model of Transporter-Mediated Drug Efflux in the Human Placental Barrier.Venous Thromboembolism Risk and Adequacy of Prophylaxis in High Risk Pregnancy in the Arabian Gulf.
P2860
Q24187670-DCD5E0C3-B0CD-4B14-B747-7FB65FBECF7EQ24235131-DB571DA5-89B4-488B-8867-37B34CB92604Q33393109-15F70DBB-891F-4BE4-946E-77B88DFB60CFQ33393738-443B1E2B-1D0F-4D68-9230-5B529C00F86DQ34447002-751615AA-C407-4AE5-A594-13E3745F500FQ36087118-F257A05A-6E28-44E7-B332-9DC39612AE31Q36619367-E0252BF3-7ED0-49E1-A347-155D4E540BD0Q37731116-D3B3E573-DE82-4422-BF12-C5067419E3FEQ38024789-7088D369-301D-42F9-89D3-719923115BCBQ43057007-0F117566-2674-44F4-820B-C9B789FD7DFDQ47271143-7B599833-4908-4E23-A1E2-00684D401964Q47278434-6B8C3068-07F5-4767-87FE-D69F5E23A5C0Q47365250-8EEE2D83-0D7F-4610-AD2A-68B29B3001BCQ55113169-8369661F-3B77-4553-9830-6531F0EC9064
P2860
The use of low-molecular-weight heparins in pregnancy--how safe are they?
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The use of low-molecular-weight heparins in pregnancy--how safe are they?
@ast
The use of low-molecular-weight heparins in pregnancy--how safe are they?
@en
type
label
The use of low-molecular-weight heparins in pregnancy--how safe are they?
@ast
The use of low-molecular-weight heparins in pregnancy--how safe are they?
@en
prefLabel
The use of low-molecular-weight heparins in pregnancy--how safe are they?
@ast
The use of low-molecular-weight heparins in pregnancy--how safe are they?
@en
P1476
The use of low-molecular-weight heparins in pregnancy--how safe are they?
@en
P2093
Capucine Coulon
P304
P356
10.1097/GCO.0B013E3282F10E33
P577
2007-12-01T00:00:00Z